Related Experiment Videos
The 'value' of values clarification in cancer-related decision aids
Objective:
A key component of decision aids (DAs) are the Value Clarification Exercises (VCEs), however, rates of completion VCEs are variable. The aim of this paper is to propose explanations for these variations.
Methods:
A review of the rates of completion and the reasons provided across eleven studies evaluating five different DAs was conducted.
Results:
Retrospective evaluation does not appear to be an indication of prospective use. Differences in mode of administration are unclear. Gender does not appear to have a difference on completion rates. Complexity of the decision appears to reflect rates of VCE completion. The main reason provided for non-completion of VCEs was that patients had already made a decision.
Conclusion:
VCEs have shown a trend to producing better congruence between values and choices, but it remains unclear how VCEs impact on the quality of the decision. Value of VCEs in treatment decision-making has not been previously established and our data indicate information alone might be enough to clarify concepts.
Practice Implications:
DAs are becoming more widely used in practice. It is important to understand the elements in a treatment decision-making so that the burden on the patient is at a minimum in practice.
Related Concept Videos
01:09Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
01:27Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:21Cancer Survival Analysis
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:30Ethical Dilemmas II
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...